View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dylan Van Haaften
  • Dylan Van Haaften

MEDIOS - BUY | EUR65 H1 results reflect NewCo consolidation

MEDIOS - BUY | EUR65 H1 results reflect NewCo consolidation Results in line with expectations Re-iterate BUY and EUR65 TP

Dylan Van Haaften ... (+2)
  • Dylan Van Haaften
  • Edward Hall

MEDIOS BUY TOP PICKS | EUR65 1Q in-line, re-iterates guidance

º Medios 1Q in-line at +60% y-oy EBITDA adjusted growth Re-iterate BUY and EUR65 TP, trading at 9.5x EBITDA

Dylan Van Haaften
  • Dylan Van Haaften

MEDIOS: No surprise in 21 results, the company ticking along | BUY | E...

MEDIOS - BUY | EUR65 No surprise in 21 results, the company ticking along In-line 2021 results Conservative FY 2022 guidance leaves room to beat. Re-iterate BUY and keep our EUR65 TP

Dylan Van Haaften
  • Dylan Van Haaften

MEDIOS: FY21 in-line, conservative and beatable FY22e guidance | BUY |...

MEDIOS - BUY | EUR65 FY21 in-line, conservative and beatable FY22e guidance In-line 2021 results We believe FY 2022 guidance is conservative Re-iterate BUY and EUR65 TP

Dylan Van Haaften
  • Dylan Van Haaften

Medios More than the Doctor ordered Healthcare | Specialty Pharma BUY ...

We initiate Medios with BUY rating and a EUR 65 price target as we believe Medios can go on to consolidate its market leading position in the specialty pharmaceutical sector in Germany. With a strong track record of growth and excellent relations with rest of the industry we believe Medios can stand to capitalise on the fast-growing specialty pharma market. We see significant upside in the share price in the light of recent acquisitions Medios’ has executed in the past 18 months with positive lo...

New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch